Tim Kaine actually said...
Five years ago, when Congress last addressed user fee reauthorization, I asked Dr. Woodcock of the FDA a question on the availability of biosimilar drugs.
Context
Kaine reflects on past discussions regarding biosimilar drug availability.
04/04/2022